Bahamas Breakouts Deliver on Catalysts, Clarity, and Credibility

In a cycle where capital is available but trust is earned deal by deal, the first in the 2026 series of CEM Events last weekend was less about big narratives and more about hard proof.

By the time the last of the roughly 1,200 curated one-on-one meetings wrapped up in the Bahamas, you could feel the mood in the room shift.

Not because the market suddenly turned euphoric, but because investors had spent 8 hours doing what they rarely get to do in public markets: sitting across from management teams, pressing on timelines, pulling apart assumptions, and watching how people respond when the questions get uncomfortable. 

“The room wasn’t rewarding the biggest promises,” said Ryan Iverson, Portfolio Manager at CEM Partners Fund, who hosted the IBE that selected the Top Picks and Outstanding Performers from a record field of 68 companies, across 13 sectors.

“It was rewarding the teams where the next milestone is clear, the path is believable, and the execution feels real.”

And that’s exactly what the Top 5 Picks from CEM’s 2026 AlphaNorth Capital Event in the Bahamas represent.

Top 5 Picks

Here is your early and exclusive look at AlphaNorth's Top Five Picks.

NYSE-American: GRO

Brazil Potash Corp.

Brazil Potash is advancing the Autazes Project in Amazonas, positioning it as a long-life domestic potash source for a country that sits at the centre of global food supply. Brazil is the world’s largest net exporter of agricultural products, with US$164 billion in agricultural exports in 2024, yet it produces less than 1% of global potash supply, a key nutrient needed to sustain crop yields at scale. Autazes is designed for 2.4 million tons per year of production, potentially supplying about 17% of Brazil’s current potash consumption. Key execution milestones include government-approved eligibility for tax concessions, start of early works construction, and binding offtake agreements that cover approximately 91% of nameplate capacity, supporting a clear path toward full construction. The company expects all production to be sold domestically while also reducing emissions via shorter riverbarge transportation routes compared with transoceanic imports.​

Why It Was Picked:

• Brazil still imports about 98% of the potash it needs, a major weak spot for a country that feeds a big share of the world. That imbalance matters because fertilizer supply is food supply. In a world where geopolitics and trade disruptions can swing pricing and availability fast, Brazil’s reliance on foreign potash is a strategic vulnerability. Brazil Potash has garnered a lot of investor interest because it is building a domestic solution that strengthens supply security for Brazil’s farms and reduces exposure to external shocks.​
• Potash is a bulk commodity, and in bulk commodities, logistics often decide who wins. Brazil Potash’s Autazes Project is positioned to serve Brazil’s core farming regions with a shorter, simpler supply chain that can reduce transportation costs and compress delivery timelines dramatically versus imported product. The company’s materials draw a sharp contrast as imported potash can take around 107 days from purchase order to delivery, while Brazil Potash estimates domestic supply could arrive in roughly 2.5 days. That speed matters for growers planning seasons and managing input costs. It also matters for pricing power because “delivered cost” is what customers feel. This advantage is structural and repeatable, not cyclical.​
• This is not a “maybe someday” exploration narrative. Brazil Potash positions Autazes as shovel ready, with key permits and licenses secured, and it has already locked in commercial validation through binding agreements that cover 91% of nameplate capacity, including major counterparties such as Amaggi, Keytrade, and Kimia Agro Solutions. That level of offtake coverage matters because it gives visibility on demand and reduces marketing risk before full production. The company also brings heavyweight credibility at the top, including Executive Chairman Mayo Schmidt, former Chairman and CEO of Nutrien.​

TSX-V: WGO

White Gold Corp.

White Gold Corp. is leveraged to a gold market that is tightening as prices climb and new large discoveries become harder to replace. Against that backdrop, the company controls one of the largest district-scale land positions in the Yukon’s emerging White Gold District, with 21 properties and 15,364 claims covering roughly 300,000 hectares or about 3,000 km², representing approximately 40% of the district.​

At the core is the flagship White Gold Project, which hosts four near-surface deposits and a combined mineral resource estimate of 1,732,300 ounces of gold in indicated resources from 35.166 million tonnes grading 1.53 g/t Au, plus 1,265,900 ounces in inferred resources from 32.297 million tonnes grading 1.22 g/t Au. The current resource base remains open for expansion along strike and at depth, while the broader portfolio continues to generate new discovery-stage targets that can feed a longer-cycle growth pipeline in a Tier 1 jurisdiction.​

Why It Was Picked:

• White Gold stands out because it combines meaningful ounces with real upside potential across a rare district-scale footprint. The White Gold Project alone contains more than 3.0 million ounces in indicated and inferred resources across four zones, with 99% of resources near surface and within an open-pit setting, giving it a cleaner path for future development work compared with deeper, more complex systems. The company also highlights additional tonnage and grade opportunities through model optimization and continued drilling, supported by targets for further exploration that point to expansion beyond the current resource envelope.​
• The company controls the exploration optionality that most juniors do not. With 300,000+ hectares across the district and multiple target trends already defined, White Gold has a pipeline that can generate new discoveries without needing to constantly acquire new ground. Within the flagship area, the company has outlined multiple untested satellite targets and broader mineralized trends such as the Ryan’s Trend and Chris Creek Trend, both positioned close to existing deposits and supported by strong geochemical signatures and drill results that suggest additional mineralized systems may be present.​
• It has execution credibility and the ability to keep advancing targets efficiently in a district that already has proven discovery history. White Gold’s technical leadership includes Chief Technical Advisor and Director Shawn Ryan, a recognized Yukon prospector tied to multiple major discoveries in the region, and the company highlights support from strategic partners including Agnico Eagle. On the ground, the company continues to generate results that can feed into the next resource update, including 2025 drilling that returned high-grade intervals at Golden Saddle and helped confirm continuity in key zones.​

CSE: VIVI

TempraMed Technologies Ltd.

TempraMed is building a scalable healthcare business around a simple problem. Many injectable medications lose effectiveness when exposed to heat or freezing once they leave controlled storage. Its FDA-registered VIVI product line uses patented, space-grade thermal insulation to protect insulin and GLP-1 pens, biologics, and emergency epinephrine in everyday conditions, without batteries or charging. The company has already sold over 120,000 units and has established distribution through major pharmacy and healthcare channels including CVS, Walgreens, Walmart, Amazon, McKesson, Target, Humana, and the U.S. Department of Veteran Affairs. With an estimated 160 million daily users of temperature-sensitive medications globally, TempraMed is pursuing a $30B+ market opportunity while expanding into reimbursement-driven adoption and connected smart devices that support recurring revenue.​

Why It Was Picked:

• TempraMed drew investor attention because it already shows market pull. The company is not asking investors to wait for a future launch. It is selling into a defined need today, with strong early traction and meaningful customer re-orders. Its technology is protected by 8 global patents, and the product design removes friction for users by working continuously without external power or maintenance. That mix of usability and defensibility supports broader adoption beyond early users and into larger healthcare channels.​
• It was also picked because access is already in place. TempraMed is distributed through some of the most important retail, pharmacy, and healthcare networks in North America, which reduces the time and cost required to build reach. Instead of relying on one sales channel, the company can grow through direct-to-consumer, retail pharmacy, and larger institutional relationships. This matters because in medical devices, distribution strength often becomes the real advantage once product fit is established.​
• Just before the AlphaNorth Event, TempraMed reported that its payor ROI model has been independently validated by Validation Institute, strengthening its case that coverage can generate measurable savings through reduced medication waste and fewer avoidable clinical events. The company is now pushing toward pilot programs that can accelerate coverage decisions. If that pathway converts, TempraMed shifts from discretionary purchases into higher-volume demand while its smart platform builds an additional layer of recurring revenue potential.​

TSX-V: CCDS

Carrier Connect Data Solutions Inc.

Carrier Connect Data Solutions is building a roll-up platform in Tier II and Tier III data centres, as AI drives a surge in demand for computing power, cooling capacity, and secure connectivity. A Tier II data center typically includes redundant components for key systems like power and cooling, while Tier III goes further with multiple distribution paths and higher fault tolerance, making it better suited for customers that need stronger uptime and disaster recovery readiness.​

Carrier’s strategy is to acquire smaller, cash-flowing facilities from private owners seeking liquidity or from non-core corporate divestitures, then scale them under a public-market growth model. The company’s operating footprint includes Vancouver, where its 200 Burrard facility delivered $360,000 in 2024 revenue and is projected at $450,000 in 2025, with a 2026 target of $750,000. Carrier has also expanded internationally through Perth, Australia with a 2MW facility and 220 racks built out, currently producing $65,000 per month with stated upside to $330,000 per month. A key recent milestone is the definitive agreement to acquire PureColo, adding Ottawa to the footprint and giving Carrier four data centres across three regions, while also strengthening its profile for U.S. investors through its OTCQB listing.​

Why It Was Picked:

• Carrier stands out because the AI-driven data center buildout is creating a supply squeeze in many markets, and the company is targeting the part of the sector that is often overlooked. Tier II and Tier III facilities are not the hyperscale giants, but they serve a large base of enterprises, service providers, and mid-market customers that still need reliable colocation, redundancy, and disaster recovery options. Carrier’s thesis is to buy these assets at private-market pricing and work toward public-market revenue multiples, where the deck highlights data centre valuations around 10x annual revenue and EBITDA potential of 40%+.​
• The company already has an operating base in Vancouver, expanded into Perth through a built, operating facility, and then moved to add Ottawa through the PureColo acquisition. PureColo brings near-term fundamentals that matter, with unaudited 2025 revenue forecast at roughly $2.35 million, gross profit of about $1.13 million, revenue growth tracking at 28% year over year, and EBITDA-positive operations. The Ottawa assets also expand Carrier’s ability to offer geographic redundancy, which is a key buying factor for customers that cannot afford downtime.​
• Carrier has a relatively tight structure with approximately 19.6 million basic shares outstanding, insider ownership around 23%, and a meaningful portion of shares escrowed, leaving a smaller free-trading float. That matters when investor attention increases, because small floats can move quickly when liquidity is limited. The company has also seen strong stock performance this year and now has a U.S. trading presence through OTCQB, widening the investor base. Add in CEO Mark Binns’ public-company scaling background and capital markets reach, and Carrier becomes a small-cap data centre consolidator that is aligned with one of the strongest infrastructure demand trends in the market.​

TSX-V: NPTH

NeuPath Health Inc.

NeuPath Health is building Canada’s largest network of chronic pain treatment facilities, operating regulated clinics that deliver specialized, procedure-based care for patients who often sit in long backlogs across the public system. The company’s model is built around experienced physicians, trained clinical teams, and high-value equipment and treatment infrastructure that is difficult to replicate quickly. NeuPath’s clinics provide a broad range of services that span injections, infusions, and rehabilitation-style care. That includes epidurals, nerve blocks, joint and bursa injections, prolotherapy, PRP, trigger point therapy, viscosupplementation, ketamine and lidocaine infusions, and complementary services such as physical therapy and radiofrequency ablation. The company operates across key high-growth population corridors in Southern Ontario and Alberta and is positioned to expand into new regions through a mix of organic growth and tuck-in acquisitions.​

Why It Was Picked:

• NeuPath was picked because it combines a large, under-served patient market with a proven operating platform that is already generating consistent positive Adjusted EBITDA and improving cash flows. The company reported its 27th consecutive quarter of positive Adjusted EBITDA in Q3 2025, highlighting that the model is not experimental and is built to produce cash flow while it scales. That consistency matters in healthcare, where growth stories often break down when clinics cannot translate patient demand into sustainable margins.​
• NeuPath improved capacity utilization to 84% in Q3 2025 and 81% year-to-date, up from 73% and 74% in the prior-year periods. Higher utilization supports stronger economics because more patient volume flows through infrastructure that is already paid for. The company has also continued investing in clinic upgrades, including new fluoroscopy suites and facility refresh work, which strengthens its ability to deliver higher-value procedures and expand patient throughput.​
• The company’s growth optionality is backed by balance sheet progress and a disciplined expansion plan. NeuPath reduced net debt from about $6.8 million at Q4 2022 to approximately $1.7 million at Q3 2025, while continuing to invest in new facilities and equipment. It also secured a new credit facility with National Bank in Q1 2025 to support growth initiatives and continues to evaluate tuck-in acquisitions, new clinic start-ups, and adjacent specialties like orthopedics that overlap with its existing patient base.​

Over the next month, the IB Newsletter will take a deep dive into each of the Top Picks through interviews with key company officials, unpacking the catalysts investors are watching most closely. We’ll also layer in the bigger forces shaping the opportunity, including geopolitics, supply and demand dynamics, and the market conditions that could turn strong execution into real upside.

OUTSTANDING PERFORMERS

Outside of the Top Picks, these 10 high-potential stories made their presence felt at the Investor Breakout Exchange in Bahamas last weekend.

1. Brazil Potash Corp.
2. White Gold Corp.
3. TempraMed Technologies Ltd.
4. Carrier Connect Data Solutions Inc.
5. NeuPath Health Inc.
6. 01 Quantum
7. Baylin Technologies Inc.
8. Tiger Gold Corp.
9. Abitibi Metals Corp.
10. Summit Royalties Corp.

HONOURABLE MENTIONS

The Bahamas field was deep. These Honourable Mentions may not have made the final Top Picks cut, but they delivered the kind of clarity and momentum that investors remember.

Performance Recap

Here’s a snapshot of how recent Investor Breakout Exchange Top Picks and Outstanding Performers have advanced in the market. (Prices as of market open on Jan. 8, 2026).

• HydroGraph Clean Power Inc. (CSE: HG) was named an Outstanding Performer at last year’s AlphaNorth Capital Event in the Bahamas and has since soared from $0.22 to $3.16, a gain of 1,336%.
• First Phosphate Corp. (CSE: PHOS) was among the companies featured at CEM’s first Bermuda Capital Event in 2023 and has since advanced from $0.48 to $1.02, a gain of 113%.
• Allied Critical Metals Inc. (CSE: ACM) drew strong investor interest at the CEM 2025 Bermuda Capital Event and has since climbed from $0.24 to $0.66, a gain of 175%.
• Carrier Connect Data Solutions Inc. (TSXV: CCDS) was named a Top Pick at CEM’s TSX Venture Growth Capital 2025 Event in Kelowna and has since moved from $0.73 to $1.50, a gain of 105%.
• Borealis Mining Company Limited (TSXV: BOGO) was a Top Pick at CEM’s 2024 Muskoka Capital Event and has since risen from $0.79 to $1.49, a gain of 89%.

Upcoming Event

Whistler Capital Event

February 6-8, 2026

CEM heads back to the mountains for its 16th Annual Whistler Capital Event, hosted at the Fairmont Chateau Whistler from February 6th to 8th, 2026. This is where growth-stage companies across resources, technology, biotech, and special situations get direct access to serious capital, not through a crowded conference floor, but through a full day of scheduled one-on-one meetings and high-quality networking. If Bahamas was about identifying who looks ready, Whistler is where those conversations often turn into real momentum.

Warm Regards and Happy Investing,
Fabian Dawson

Weekly Insight

Each week, CEM Partner and Portfolio Manager Ryan Iverson spotlights the ideas and companies sparking investor interest from emerging growth stories to the Top Picks featured across CEM’s Capital Events. This series brings real insights from the innovators shaping tomorrow’s markets and reveals where investors are finding the next breakout opportunities.

Stay informed. Stay ahead. Stay with the Investor Breakout Exchange:
X | Facebook | LinkedIn | Instagram | YouTube | TikTok